Adam Leo Stone
Lead Independent DirectorMr. Adam Leo Stone serves as Chief Investment Officer of Perceptive Advisors LLC from March 2025. He serves as CEO and Director at Perceptive Capital Solutions Corp since March 2024. He is an Independent Non-Executive Director of Immatics N.V. from July 01, 2021. He is Lead Independent Director of Solid Biosciences Inc. He is Director of Xontogeny LLC. He is Director of Renovia Inc. He is Co-Owner of Arya Sciences Holdings Ii. He is Co-Owner of ARYA Sciences Holdings III. He is Interim Chief Executive Officer of LianMedical from December 2023. He is Director of LianMedical from October 2019. He is CEO and Director of ARYA Sciences Acquisition Corp IV from January 2021. He is Co-Owner of ARYA Sciences Holdings IV. He is CEO and Director of ARYA Sciences Acquisition Corp V from March 2021. He is Co-owner of Arya Sciences Holdings V. He serves on the board of directors of PROMETHERA Biosciences S.A./N.V. He joined the Perceptive Advisors LLC in 2006. He was Chief Investment Officer and Head of Research of Perceptive Advisors LLC until March 2025. Prior to joining Perceptive Advisors, Mr. Stone was a Senior Analyst at Ursus Capital from 2001 to 2006 where he focused on biotechnology and specialty pharmaceuticals. He was Supervisory Director of Immatics N.V. from July 01, 2020 to July 01, 2021. He was Independent Director of Solid Biosciences Inc. from November 2015. He was CEO and Director of ARYA Sciences Acquisition Corp. He was CEO and Director of ARYA Sciences Acquisition Corp II. He was CEO and Director of ARYA Sciences Acquisition Corp III from July 2020. He has a B.A. in Molecular Biology from Princeton University.
Positions
- Company NameSolid Biosciences Inc.Stock CodeSLDBPositionLead Independent DirectorColleagues
- Company NameLianMedicalStock CodeLIANYPositionInterim CEO & Director
